Related Experiment Video
Updated: Sep 20, 2025

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
Cabreuvanols A-C, three new cassane-derived diterpenes from Myrocarpus frondosus and their anti-inflammatory effects
Ana C da Silva1, Tiago Tizziani1, Tainá L Lubschinski2
1Department of Chemistry, Federal University of Santa Catarina, Campus Universitário-Trindade, 88040-900 Florianópolis, SC, Brazil.
Abstract:
Three previously unreported cassane-type diterpenoids (2-4), were purified from Myrocarpus frondosus roots alongside four known compounds (1, 5-7). Their structures were established based on spectroscopic and spectrometric data as cabreuvanols A-C (2-4) and ayapin (1), afromosin 7-O-β-D-apiofuranosyl-(1 → 2)-glucopyranoside (5), thyrsifloside (6) and afromosin 7-O-β-D-glucopyranoside (7). The absolute configuration of compound 2 was determined by using X-ray crystallography experiments. The crude extract (CE), fractions (MF, EAF, and DCMF) and compounds 1-3 were evaluated for their cytotoxicity against the mouse macrophage J774 and their inhibitory effects against inflammatory biomarkers. Except for MF, others showed high CC10 values against the macrophage. On the other hand, compound 3 was more cytotoxic than others. CE and EAF inhibited NOx production at doses of 10, 3, and 1 μg/mL in a range of 82.2 ± 4.2 and 68.6 ± 4.8 %, whereas DCMF displayed almost a constant activity between 78.9 ± 1.0 and 72.7 ± 1.5 % at three doses. Compounds 1 and 2 moderately reduced NOx in a range of 58.6 ± 4.7 and 23.4 ± 8.8 %. These samples also reduced NOx, myeloperoxidase, exudation, and cell migration from the bronchoalveolar lavage in the in vivo experimental model of acute pulmonary inflammation (ALI).
More Related Videos
07:59A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
Published on: October 4, 2019
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
Related Concept Videos
Carboxylic Acid Derivatives: Overview
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Inflammation
Antiasthma Drugs: Muscarinic Receptor Antagonists
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...